Literature DB >> 9740330

Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.

K A Lamb1, A Rizzino.   

Abstract

Embryonal carcinoma (EC) cells are used widely as a model system for studying the expression of developmentally regulated genes, in particular genes that are regulated at the transcriptional level when EC cells differentiate. This review focuses on the molecular mechanisms that govern the transcription of the fibroblast growth factor-4 (FGF-4) gene, which appears to be the first FGF expressed during mammalian development. Interest in this gene has increased considerably with the finding that FGF-4 is essential for mammalian embryogenesis. The FGF-4 gene has also generated considerable interest because it is inhibited at the transcriptional level when EC cells undergo differentiation and because this gene is regulated by a powerful distal enhancer located 3 kb downstream of the transcription start site in the last exon of the gene. Hence, study of the FGF-4 gene is likely to shed light on the molecular mechanisms by which distal enhancers regulate gene expression. In addition to being regulated by the downstream enhancer, the expression of this gene is influenced by a regulatory region located just upstream of the transcription start site, which contains two Sp1 motifs and a CCAAT box motif. Examination of the downstream enhancer has identified three functional cis-regulatory elements: a high mobility group (HMG) protein binding motif, an octamer binding motif, and an Sp1 motif, which are likely to bind Sox-2, Oct-3, and Sp1/Sp3, respectively, in vivo. Interestingly, Sox-2 and Oct-3 expression, like FGF-4 expression, decreases when EC cells differentiate, which suggests that the loss of these transcription factors is responsible, at least in part, for the transcriptional turn-off of the FGF-4 gene. In view of these and other findings, we present a model for the differential expression of the FGF-4 gene that includes not only the contributions of specific transcription factors, but also the contribution of chromatin structure before and after differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740330     DOI: 10.1002/(SICI)1098-2795(199810)51:2<218::AID-MRD12>3.0.CO;2-0

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  10 in total

1.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

2.  Cross-species transcriptional profiles establish a functional portrait of embryonic stem cells.

Authors:  Yu Sun; Huai Li; Ying Liu; Soojung Shin; Mark P Mattson; Mahendra S Rao; Ming Zhan
Journal:  Genomics       Date:  2006-10-19       Impact factor: 5.736

3.  Varying coefficient model for gene-environment interaction: a non-linear look.

Authors:  Shujie Ma; Lijian Yang; Roberto Romero; Yuehua Cui
Journal:  Bioinformatics       Date:  2011-06-20       Impact factor: 6.937

4.  Related function of mouse SOX3, SOX9, and SRY HMG domains assayed by male sex determination.

Authors:  D E Bergstrom; M Young; K H Albrecht; E M Eicher
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

5.  Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer.

Authors:  Huan Zhou; Y U Hu; Weipeng Wang; Yong Mao; Jingjie Zhu; Bin Zhou; Jing Sun; Xueguang Zhang
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

6.  Functional interactions between Drosophila bHLH/PAS, Sox, and POU transcription factors regulate CNS midline expression of the slit gene.

Authors:  Y Ma; K Certel; Y Gao; E Niemitz; J Mosher; A Mukherjee; M Mutsuddi; N Huseinovic; S T Crews; W A Johnson; J R Nambu
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

7.  Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis.

Authors:  Hsin-I Ma; Chung-Lan Kao; Yi-Yen Lee; Guang-Yuh Chiou; Lung-Kuo Tai; Kai-Hsi Lu; Chi-Shuan Huang; Yi-Wei Chen; Shih-Hwa Chiou; Ing-Chan Cheng; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

8.  The EWS-Oct-4 fusion gene encodes a transforming gene.

Authors:  Jungwoon Lee; Ja Young Kim; In Young Kang; Hye Kyoung Kim; Yong-Mahn Han; Jungho Kim
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

9.  Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.

Authors:  Yu-Chih Chen; Han-Shui Hsu; Yi-Wei Chen; Tung-Hu Tsai; Chorng-Kuang How; Chien-Ying Wang; Shih-Chieh Hung; Yuh-Lih Chang; Ming-Long Tsai; Yi-Yen Lee; Hung-Hai Ku; Shih-Hwa Chiou
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

10.  Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.

Authors:  Boon-Yin Khoo; Kalpanah Nadarajan; Siang-Yian Shim; Noorizan Miswan; Chuan-Bing Zang; Kurt Possinger; Elena Elstner
Journal:  Mol Med Rep       Date:  2016-03-02       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.